×
About 116,815 results

ALLMedicine™ Heart Failure Center

Research & Reviews  39,191 results

Acute Effects of Left Ventricular Support With Impella 5.5 on Biventricular Hemodynamics.
https://doi.org/10.1161/CIRCHEARTFAILURE.121.008616
Circulation. Heart Failure; Everett KD, Jain P et. al.

Sep 15th, 2021 - Identification of patients with cardiogenic shock and right ventricle (RV) dysfunction who may require biventricular rather than isolated left ventricular (LV) support remains challenging. In this setting, rigorous hemodynamic evaluation of bivent...

The Dilemma of Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejec...
https://doi.org/10.1053/j.jvca.2021.08.024
Journal of Cardiothoracic and Vascular Anesthesia; Cormican DS, Czerny M et. al.

Sep 15th, 2021 - The Dilemma of Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction: Are We Waiting Too Long to Intervene, or Should We Wait for More Evidence?|2021|Cormican DS,Czerny M,Ramakrishna H,|

Renal denervation based on experimental rationale.
https://doi.org/10.1038/s41440-021-00746-7 10.1007/s11906-015-0570-0 10.1161/01.CIR.73.4.615 10.1038/nrn1902 10.1016/j.autneu.2016.08.008 10.1152/ajpheart.00862.2014 10.1002/cphy.c150047 10.1152/ajpheart.00722.2011 10.1002/cne.902220408 10.1016/j.autneu.2010.11.001 10.1161/HYPERTENSIONAHA.113.00801 10.1161/HYPERTENSIONAHA.116.08242 10.1161/CIRCRESAHA.109.208645 10.1093/cvr/cvr242 10.1161/HYPERTENSIONAHA.119.13133 10.1161/HYPERTENSIONAHA.119.12675 10.1161/01.HYP.36.6.1023 10.1161/hyp.38.4.896 10.1152/ajpheart.00503.2001 10.1161/HYPERTENSIONAHA.111.176222 10.1113/EP086744 10.1161/hy0202.102701 10.1291/hypres.26.325 10.1161/01.HYP.0000050649.30821.CB 10.1161/01.HYP.36.2.259 10.1161/01.RES.0000135483.12297.e4 10.1161/01.CIR.0000128695.49900.12 10.1097/HJH.0b013e32834e1df4 10.1097/HJH.0b013e32835613d7 10.1016/j.brainres.2019.02.004 10.1152/ajpheart.00510.2018 10.1161/HYPERTENSIONAHA.115.05333 10.1161/HYPERTENSIONAHA.112.192252 10.1113/JP272065 10.1016/S0140-6736(20)30554-7 10.1016/S0140-6736(18)30951-6 10.1161/HYPERTENSIONAHA.120.15745 10.1139/y87-244 10.1152/ajpregu.00427.2014 10.1161/HYPERTENSIONAHA.118.11071 10.1161/HYPERTENSIONAHA.116.07850 10.1097/HJH.0000000000002304 10.1007/s00424-019-02346-4 10.3389/fphys.2020.601237 10.1152/ajpregu.00408.2015 10.1161/CIRCRESAHA.115.306010 10.1016/0165-1838(83)90110-8 10.1002/cne.902160205 10.1016/0006-8993(84)91154-5 10.1016/S0006-8993(01)03030-X 10.1186/s12933-020-01029-0 10.1161/HYPERTENSIONAHA.115.06794 10.1152/ajpregu.00057.2014 10.1007/s00395-010-0146-8 10.1152/ajpheart.00299.2019 10.1016/j.jacc.2018.08.2186 10.1152/ajpheart.00999.2015 10.1016/S0140-6736(09)60566-3 10.1016/S0140-6736(13)62192-3 10.1093/eurheartj/ehu209 10.1056/NEJMoa1402670 10.1016/S0140-6736(18)31082-1 10.1161/CIRCULATIONAHA.119.040451 10.1016/j.jcin.2020.09.054 10.1016/S0140-6736(21)00788-1 10.1056/NEJM199212313272704 10.1016/S0895-7061(98)00154-X 10.1016/j.nicl.2014.08.021 10.1007/s11325-014-0991-z 10.1161/HYPERTENSIONAHA.120.16378 10.1111/jch.12759 10.1016/S0895-7061(03)00567-3 10.1161/01.CIR.0000056521.67546.AA 10.1161/HYPERTENSIONAHA.116.07201 10.1161/HYPERTENSIONAHA.118.12740 10.1161/CIRCULATIONAHA.120.049730 10.1016/j.jacc.2021.04.044 10.1016/j.jacc.2014.11.071 10.1161/HYPERTENSIONAHA.113.02266
Hypertension Research : Official Journal of the Japanese ... Katsurada K, Ogoyama Y et. al.

Sep 15th, 2021 - Excessive activation of the sympathetic nervous system is one of the pathophysiological hallmarks of hypertension and heart failure. Within the central nervous system, the paraventricular nucleus (PVN) of the hypothalamus and the rostral ventrolat...

The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1.
https://doi.org/10.1159/000518553
Cardiorenal Medicine; Virzì GM, Clementi A et. al.

Sep 15th, 2021 - Recent research highlighted the potential role of circulating cell-free DNA (cfDNA), resulted by apoptosis or cell necrosis, as a prognostic marker in the setting of different clinical conditions. Cardiorenal syndrome type 1 (CRS type 1) is charac...

see more →

Guidelines  76 results

2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary...
https://doi.org/10.1016/j.jtcvs.2021.04.052
The Journal of Thoracic and Cardiovascular Surgery; Bakaeen FG, Gaudino M et. al.

Jul 18th, 2021 - 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.|2021|Bakaeen FG,Gaudino M,Whitman G,Doenst T,Ruel M,|standards,diagnostic im...

Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation R...
https://doi.org/10.1001/jama.2021.4987
JAMA , Krist AH et. al.

Apr 28th, 2021 - Hypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardia...

Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emer...
https://doi.org/10.7326/M20-7844
Annals of Internal Medicine; Qaseem A, Etxeandia-Ikobaltzeta I et. al.

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care...
https://doi.org/10.1016/j.cjca.2021.01.017
The Canadian Journal of Cardiology; McDonald M, Virani S et. al.

Apr 9th, 2021 - In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we provide comprehensive recommendations and practical tips for the pharmacologic management of patients with HF with reduced ejection fraction (HFrEF). Since the...

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart...
https://doi.org/10.1016/j.jacc.2020.11.022
Journal of the American College of Cardiology; , Maddox TM et. al.

Jan 16th, 2021 - 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set...

see more →

Drugs  1,944 results see all →

Clinicaltrials.gov  98 results

Thoracentesis to Alleviate Cardiac Pleural Effusion
https://clinicaltrials.gov/ct2/show/NCT05017753

Sep 9th, 2021 - Purpose and Rationale: Pleural effusion is a common presentation in patients with heart failure, and the condition is related to a poor prognosis and increased mortality. Therapeutic options consist of intensification of diuretic treatment and inv...

SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pil...
https://clinicaltrials.gov/ct2/show/NCT05037695

Sep 8th, 2021 - Prospective, unblinded, randomized (1:1), single-center pilot study of 40 patients allocated to one of the treatment arms (OMT + empaglifozin or OMT). Strategies to reduce Contrast-induced acute kidney injury will be used in both study arms The st...

Remote Monitoring of AF Recurrence Using mHealth Technology
https://clinicaltrials.gov/ct2/show/NCT05037136

Sep 8th, 2021 - Atrial fibrillation (AF) is the most common arrhythmia worldwide. It carries a significant health burden, conferring on sufferers a reduction in quality of life, risk of significant morbidities such as stroke and heart failure, and significant mor...

Efficacy of Clarithromycin and Flouroquinolones Based Regimens in H.Pylori Eradication in Covid-19 Era
https://clinicaltrials.gov/ct2/show/NCT05035186

Sep 5th, 2021 - Era of COVID-19 and the related panic lead to widely spread antibiotics misuse especially for azithromycin. Cross sensitivity between azithromycin and clarithromycin can impact success rates of H. pylori treatment regimens.(1) Here we aim to explo...

Virtual Remote Physiological Monitoring Program of Children With Heart Disease
https://clinicaltrials.gov/ct2/show/NCT05034354

Sep 5th, 2021 - This will be a prospective multi-methods observational study. We will assess the feasibility of the novel home-based remote physiological monitoring (RPM) system paired to a smartphone app (Sphygmo™) and linked to a secure physician platform. We w...

see more →

News  5,401 results

New FDA Guidance on T2D Trial Design Provides Flexibility
https://www.medscape.com/viewarticle/954346

Jul 20th, 2021 - This transcript has been edited for clarity. The story of cardiovascular outcomes in diabetes is a fascinating one. There were new developments in the regulatory landscape that really drove the past 10 years of history. If you go way back to the f...

Fast Five Quiz: Type 2 Diabetes and Heart Failure
https://www.medscape.com/viewarticle/940633

Jul 15th, 2021 - The increased prevalence of type 2 diabetes and heart failure highlights the need for optimal strategies for comanaging these diseases. An estimated 26.9 million Americans, or 8.2% of the US population, have diabetes; an additional 6.2 million hav...

Darolutamide Demonstrates Favorable Tolerability in Nonmetastatic CRPC
https://www.onclive.com/view/darolutamide-demonstrates-favorable-tolerability-in-nonmetastatic-crpc

Jul 12th, 2021 - Treatment with darolutamide (Nubeqa) induced a low cumulative incidence of hormone treatment–related adverse effects (HTR AEs) that was comparable to treatment with placebo in patients with nonmetastatic castration-resistant prostate cancer (CRPC)...

Secondary Mitral Regurgitation Common, Undertreated in HF
https://www.medscape.com/viewarticle/954607

Jul 12th, 2021 - Secondary mitral regurgitation (sMR) is common in patients with heart failure (HF) and is associated with increased mortality, but it is undertreated, according to a new study. Investigators analyzed data from more than 13,000 HF patients in an Au...

IV Iron Cost-Effective, Maybe Even Cost-Saving in HF With Iron Deficiency
https://www.medscape.com/viewarticle/954455

Jul 8th, 2021 - Intravenous iron therapy was predicted to be highly cost-effective or even cost-saving when used in high-risk, iron-deficient patients with heart failure (HF) in each of four different countries with different healthcare payment systems, in an ana...

see more →

Patient Education  16 results see all →